Insider Transactions Reported by 13 Insiders of ACTUATE THERAPEUTICS, INC.

Symbol
ACTU on Nasdaq
Location
Fort Worth, TX

Insiders trading volume in the past year

ACTUATE THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.l. Fletcher Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
Leslie W. Kreis Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
Bios Equity COF, LP Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
Todd S. Thomson Director, 10%+ Owner $16,003,463 -$1,624,000 -9.2% 05 Jan 2026
Daniel M. Schmitt President, CEO and Director, Director $4,851,010 13 Feb 2026
Roger Sawhney Director 22 May 2025
Amy L. Ronneberg Director 22 May 2025
Jason A. Keyes Director 22 May 2025
Andrew Paul Mazar Chief Operating Officer 01 Apr 2025
Bios 2024 Co-Invest, LP Director, Member of 10% Group 14 Aug 2024
Bios Clinical Opportunity Fund, LP 10%+ Owner 12 Aug 2024
Paul J. Lytle Chief Financial Officer 01 Apr 2025
Dan Zabrowski Director 22 May 2025

Recent Insider Transactions by Companies or Individuals for ACTUATE THERAPEUTICS, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Daniel M. Schmitt ACTU Common Stock Tax liability -44.8% -121,874 150,181 13 Feb 2026 Direct
Daniel M. Schmitt ACTU Common Stock Options Exercise 272,055 272,055 13 Feb 2026 Direct
Daniel M. Schmitt ACTU Restricted Stock Units Options Exercise -50% -272,055 272,056 13 Feb 2026 Direct
Todd S. Thomson ACTU Common Stock Sale -23.6% $1,624,000 $5.80 -280,000 904,795 05 Jan 2026 By Kairos Venture Partners II, L.P.
Bios Equity COF, LP ACTU Common Stock Purchase 57.1% $499,996 $7.00 71,428 196,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Bios Equity COF, LP ACTU Warrant (Right to Buy) Purchase 71,428 71,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Leslie W. Kreis ACTU Common Stock Purchase 57.1% $499,996 $7.00 71,428 196,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Leslie W. Kreis ACTU Warrant (Right to Buy) Purchase 71,428 71,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Aaron G.l. Fletcher ACTU Common Stock Purchase 57.1% $499,996 $7.00 71,428 196,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Aaron G.l. Fletcher ACTU Warrant (Right to Buy) Purchase 71,428 71,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Todd S. Thomson ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Roger Sawhney ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Dan Zabrowski ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Aaron G.l. Fletcher ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Jason A. Keyes ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Amy L. Ronneberg ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Daniel M. Schmitt ACTU Employee Stock Option (right to buy) Award 270,788 204,285 01 Apr 2025 Direct
Andrew Paul Mazar ACTU Employee Stock Option (right to buy) Award 161,392 110,346 01 Apr 2025 Direct
Paul J. Lytle ACTU Employee Stock Option (right to buy) Award 91,293 49,394 01 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.